Removal of Cytokines During Extracorporeal Circulation in Cardiac Surgery

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

September 30, 2013

Primary Completion Date

October 31, 2015

Study Completion Date

August 31, 2017

Conditions
Coronary Artery DiseaseHeart Valve Diseases
Interventions
DEVICE

CytoSorb device

In 20 patients the CytoSorb device will be installed into the extra corporeal circuit. A blood flow of 400ml/min is provided by an roller pump of the heart lung machine in a parallel stream to the main circulation.

Trial Locations (1)

20246

Department of Anaesthesiology Center of Anaesthesiology and Intensive Care Medicine University Medical Center Hamburg-Eppendorf University of Hamburg, Hamburg

All Listed Sponsors
lead

Universitätsklinikum Hamburg-Eppendorf

OTHER

NCT02297334 - Removal of Cytokines During Extracorporeal Circulation in Cardiac Surgery | Biotech Hunter | Biotech Hunter